Explore: Suppurativa

hidradenitis suppurativa. JAMA Dermatol. 2018. Sabat R, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020. Burden of Hidradenitis Suppurativa: A Systematic

Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is administered by subcutaneous injection (injection

defined more generally as an inflammation of sweat glands. Hidradenitis suppurativa is a chronic cutaneous condition originally thought to be primarily characterized

arthritis, axial spondyloarthritis, ankylosing spondylitis, and hidradenitis suppurativa. The most common side effects include upper respiratory tract infections

with clindamycin has been used to treat the skin disease hidradenitis suppurativa. The most serious adverse effect is hepatotoxicity, and people receiving

being evaluated for the treatment of the skin conditions hidradenitis suppurativa and chronic prurigo. It is a JAK1 inhibitor. Alavi A, Hamzavi I, Brown

applied to skin or taken by mouth, may also be used in hidradenitis suppurativa. Common adverse drug reactions associated with systemic clindamycin therapy –

C6H4(OH)(O–COCH3), is used under the name of Euresol. It is used in hidradenitis suppurativa with limited evidence showing it can help with resolution of the lesions

Hidradenitis Suppurativa and Crohn's Disease". In Jemec, Gregor B. E.; Revuz, Jean; Leyden, James J. (eds.). Hidradenitis Suppurativa. Springer. p. 53

alternate names that respectively refer to the skin conditions hidradenitis suppurativa (HS) and rosacea. Although HS shares certain overlapping features with